Puma Biotechnology Inc Stock Nyse
Equities
US74587V1070
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.945 USD | -90.42% | -5.60% | -47.95% |
Financials (USD)
Sales 2024 * | 231M | Sales 2025 * | 233M | Capitalization | 241M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 14M | EV / Sales 2024 * | 1.04 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
29.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.88% |
Latest transcript on Puma Biotechnology Inc
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
1st Jan change | Capi. | |
---|---|---|
-2.04% | 41.35B | |
+42.15% | 40.38B | |
+1.62% | 39.05B | |
-14.19% | 26.67B | |
+1.73% | 24.07B | |
-24.25% | 18.36B | |
-3.85% | 11.68B | |
+21.33% | 11.6B | |
+7.66% | 11.15B |